Filing Details

Accession Number:
0001209191-22-046962
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-19 21:40:05
Reporting Period:
2022-08-17
Accepted Time:
2022-08-19 21:40:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1652724 Lucira Health Inc. LHDX In Vitro & In Vivo Diagnostic Substances (2835) 272491037
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1877741 Ghazi Kashmolah 1412 62Nd Street
Emeryville CA 94608
Ex Vp & Chief Quality Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-08-17 19,074 $2.83 180,757 No 4 S Direct
Common Stock Disposition 2022-08-18 3,500 $2.25 177,257 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30, 2021 for 197,240 shares.
  2. Includes 2,591 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on February 20, 2022.